Ghrelin for Cancer Cachexia: Treating the Devastating Muscle Wasting of Advanced Cancer

Ghrelin shows promise for treating cancer cachexia through combined appetite stimulation, GH-mediated anabolism, and anti-inflammatory effects — addressing the multi-factorial wasting that kills many cancer patients.

DeBoer, Mark Daniel·Nutrition (Burbank·2008·Moderate EvidenceReview
RPEP-01329ReviewModerate Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Ghrelin addresses cancer cachexia through triple mechanism: appetite stimulation (reversing anorexia), GH/IGF-1-mediated anabolism (opposing muscle wasting), and anti-inflammatory effects (countering inflammatory cytokine-driven catabolism) — emerging as the most comprehensive cachexia therapy.

Key Numbers

How They Did This

review study.

Why This Research Matters

Relevant for ghrp, cancer, weight-loss.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Ghrelin addresses cancer cachexia through triple mechanism: appetite stimulation (reversing anorexia), GH/IGF-1-mediated anabolism (opposing muscle wa
Evidence Grade:
moderate evidence.
Study Age:
Published in 2008.
Original Title:
Emergence of ghrelin as a treatment for cachexia syndromes.
Published In:
Nutrition (Burbank, Los Angeles County, Calif.), 24(9), 806-14 (2008)
Database ID:
RPEP-01329

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Ghrelin for Cancer Cachexia: Treating the Devastating Muscle Wasting of Advanced Cancer

What was found?

Ghrelin shows promise for treating cancer cachexia through combined appetite stimulation, GH-mediated anabolism, and anti-inflammatory effects — addressing the multi-factorial wasting that kills many cancer patients.

Read More on RethinkPeptides

Cite This Study

RPEP-01329·https://rethinkpeptides.com/research/RPEP-01329

APA

DeBoer, Mark Daniel. (2008). Emergence of ghrelin as a treatment for cachexia syndromes.. Nutrition (Burbank, Los Angeles County, Calif.), 24(9), 806-14. https://doi.org/10.1016/j.nut.2008.06.013

MLA

DeBoer, Mark Daniel. "Emergence of ghrelin as a treatment for cachexia syndromes.." Nutrition (Burbank, 2008. https://doi.org/10.1016/j.nut.2008.06.013

RethinkPeptides

RethinkPeptides Research Database. "Emergence of ghrelin as a treatment for cachexia syndromes." RPEP-01329. Retrieved from https://rethinkpeptides.com/research/deboer-2008-emergence-of-ghrelin-as

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.